Ingo B. Runnebaum
Klinik und Poliklinik für Frauenheilkunde und Fortpflanzungsmedizin
Papers
2
Total Citations
20
H-Index
2
About
Ingo B. Runnebaum is a leading figure in gynecologic oncology, with a research focus on advancing minimally invasive surgical techniques for the treatment of gynecologic cancers, particularly cervical and endometrial malignancies. His major contributions include critical evaluation of surgical standards, most notably through his commentary on the landmark LACC trial (Laparoscopic Approach to Cervical Cancer), which has shaped international guidelines by questioning the safety of minimally invasive radical hysterectomy for early-stage cervical cancer—a paper cited 17 times. Dr. Runnebaum has also pioneered research into the feasibility and safety of robotic-assisted gynecological surgery in older patients, demonstrating that women over 65 can undergo these procedures with favorable perioperative outcomes despite higher comorbidity burdens. His work directly addresses the challenges of an aging population, bridging surgical innovation with patient-centered care. With a career dedicated to improving surgical safety and outcomes, Runnebaum’s research continues to influence clinical practice, offering evidence that advanced age need not be a barrier to accessing state-of-the-art, minimally invasive gynecologic oncology care.
Research Focus
Key Achievements
Top Papers
- 1
- 2